Research has shown that integrating anything at this scale into human daily life could lead to overuse and addiction. So what does all this screentime mean for our long-term mental and physical health?
Uncontrolled blood pressure puts people at increased risk of developing heart disease, brain disease, and kidney disease, yet only one in four people have their blood pressure under good control.
Rakesh Jain PhD, Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk Cook Professor of Radiation Oncology at Harvard Medical School, is senior author of a new study in PNAS, Targeting EPHB2/ABL1 Restores Anti-Tumor Immunity in Preclinical Models of Ependymoma.
A randomized three-year clinical trial recently released shows fish oil high in omega-3 fatty acids provides statistically significant benefit for those genetically predisposed to Alzheimer’s. McCance Center’s Dr. Gene Bowman is senior corresponding author.
Mass General Brigham researchers found that for people with HIV in the REPRIEVE trial, current risk models underestimated cardiovascular events in both women and black men in high-income countries, while overestimating cardiovascular events in low- and middle-income countries
The McCance Center has launched an ambitious program to prevent Alzheimer’s disease (AD) – “The Pre-AD Initiative” (Prediction and Prevention of Alzheimer’s Disease).
The journal Nature recently published The History of Alzheimer’s Disease, with a timeline from 1906 – 2024. This chart maps major developments that have helped shape current research on Alzheimer's disease. Three key discoveries from McCance Center Director Dr. Rudy Tanzi’s lab are featured in the chronology in 1987,1995 and 2008.
Inactivating one X chromosome is critically important in female cells, but what prevents the same mechanism from turning off other chromosomes? A new Mass General Brigham study may hold the answers
Researchers found that injectable naltrexone had the fewest reported GI and liver-related side effects compared to the other drugs.
Researchers used a unique 3D microfluidic model of tumors to investigate the mechanisms of treatment resistance to CAR-T cells.
Members of the media can reach the media relations team by email or phone.
